Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2014

01-05-2014

Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices

Authors: Robby Nieuwlaat, John W. Eikelboom, Sam Schulman, Harriette G. C. van Spall, Karleen M. Schulze, Benjamin J. Connolly, Spencer M. Cuddy, Lowiek M. Hubers, Alexander C. Stehouwer, Stuart J. Connolly

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2014

Login to get access

Abstract

Many patients using warfarin are being managed in primary care and typically achieve a lower time in therapeutic range (TTR) for the international normalized ratio (INR) than patients in specialized care. A simple warfarin maintenance dosing tool could assist primary care physicians with improving TTR. We tested whether a simple warfarin maintenance dosing algorithm can improve TTR compared with usual care among Canadian primary care physicians. Primary care practices managing warfarin therapy without an anticoagulation clinic, computer decision support system or patient self-management tools enrolled 10–30 patients with target INR range 2–3. Practices were randomized to manage warfarin maintenance with the algorithm, or as usual in 2009–2010. Primary outcome was the mean individual patient TTR, and was compared between groups with adjustment for clustering within practices. There were 13 practices randomized to the Algorithm and 15 practices to Control, enrolling 240 and 297 patients respectively, with a mean follow-up of 280 days. Mean (standard deviation; SD) TTR before the study was comparable between groups [68 % (SD 26) for usual care vs. 70 % (SD 27) for the algorithm; p = 0.49]. Dosing decisions during the study in the algorithm group were more often in agreement with the algorithm’s recommendations than with usual care (81 vs. 91 %; p < 0.0001). Mean study TTR of the algorithm group was not superior to usual care: [72.1 (SE 1.7) vs. 71.4 % (SE 1.5) respectively; p = 0.73]. The simple warfarin maintenance dosing algorithm did not improve TTR compared with usual care among Canadian primary care practices.
Appendix
Available only for authorised users
Literature
1.
go back to reference Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH (2012) Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e152S–e184S. doi:10.1378/chest.11-2295 PubMedCentralPubMedCrossRef Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, Svensson PJ, Veenstra DL, Crowther M, Guyatt GH (2012) Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e152S–e184S. doi:10.​1378/​chest.​11-2295 PubMedCentralPubMedCrossRef
2.
go back to reference Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y (2008) Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 1:84–91. doi:10.1161/CIRCOUTCOMES.108.796185 PubMedCrossRef Wan Y, Heneghan C, Perera R, Roberts N, Hollowell J, Glasziou P, Bankhead C, Xu Y (2008) Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 1:84–91. doi:10.​1161/​CIRCOUTCOMES.​108.​796185 PubMedCrossRef
3.
go back to reference Nieuwlaat R, Connolly SJ, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL, Brian HR (2011) Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review. Implement Sci 6:90. doi:10.1186/1748-5908-6-90 PubMedCentralPubMedCrossRef Nieuwlaat R, Connolly SJ, Mackay JA, Weise-Kelly L, Navarro T, Wilczynski NL, Brian HR (2011) Computerized clinical decision support systems for therapeutic drug monitoring and dosing: a decision-maker-researcher partnership systematic review. Implement Sci 6:90. doi:10.​1186/​1748-5908-6-90 PubMedCentralPubMedCrossRef
4.
go back to reference van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ (2006) Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 129:1155–1166PubMedCrossRef van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ (2006) Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 129:1155–1166PubMedCrossRef
5.
go back to reference Nieuwlaat R, Connolly B, Eikelboom J, Connolly S, Kaatz S (2010) Systematic review to identify validated manual warfarin maintenance dosing tools. Blood 116 Nieuwlaat R, Connolly B, Eikelboom J, Connolly S, Kaatz S (2010) Systematic review to identify validated manual warfarin maintenance dosing tools. Blood 116
6.
go back to reference Van Spall HG, Wallentin L, Yusuf S, Eikelboom JW, Nieuwlaat R, Yang S, Kabali C, Reilly PA, Ezekowitz MD, Connolly SJ (2012) Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation 126:2309–2316. doi:10.1161/CIRCULATIONAHA.112.101808 PubMedCrossRef Van Spall HG, Wallentin L, Yusuf S, Eikelboom JW, Nieuwlaat R, Yang S, Kabali C, Reilly PA, Ezekowitz MD, Connolly SJ (2012) Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial. Circulation 126:2309–2316. doi:10.​1161/​CIRCULATIONAHA.​112.​101808 PubMedCrossRef
7.
go back to reference Kim YK, Nieuwlaat R, Connolly SJ, Schulman S, Meijer K, Raju N, Kaatz S, Eikelboom JW (2010) Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. J Thromb Haemost 8:101–106. doi:10.1111/j.1538-7836.2009.03652.x PubMedCrossRef Kim YK, Nieuwlaat R, Connolly SJ, Schulman S, Meijer K, Raju N, Kaatz S, Eikelboom JW (2010) Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study. J Thromb Haemost 8:101–106. doi:10.​1111/​j.​1538-7836.​2009.​03652.​x PubMedCrossRef
8.
go back to reference Nieuwlaat R, Hubers LM, Spyropoulos AC, Eikelboom JW, Connolly BJ, Van Spall HG, Schulze KM, Cuddy SM, Stehouwer AC, Schulman S, Connolly SJ (2012) Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy. Thromb Haemost 108:1228–1235. doi:10.1160/TH12-06-0433 PubMedCrossRef Nieuwlaat R, Hubers LM, Spyropoulos AC, Eikelboom JW, Connolly BJ, Van Spall HG, Schulze KM, Cuddy SM, Stehouwer AC, Schulman S, Connolly SJ (2012) Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy. Thromb Haemost 108:1228–1235. doi:10.​1160/​TH12-06-0433 PubMedCrossRef
9.
go back to reference Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026PubMedCrossRef Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE (2003) Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349:1019–1026PubMedCrossRef
10.
go back to reference Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–239PubMed Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E (1993) A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 69:236–239PubMed
12.
go back to reference Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151. doi:10.1056/NEJMoa0905561 PubMedCrossRef Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151. doi:10.​1056/​NEJMoa0905561 PubMedCrossRef
13.
go back to reference Donner A, Klar N (2000) Design and analysis of cluster randomization trials in health research. Arnold Publishers, London Donner A, Klar N (2000) Design and analysis of cluster randomization trials in health research. Arnold Publishers, London
Metadata
Title
Cluster randomized controlled trial of a simple warfarin maintenance dosing algorithm versus usual care among primary care practices
Authors
Robby Nieuwlaat
John W. Eikelboom
Sam Schulman
Harriette G. C. van Spall
Karleen M. Schulze
Benjamin J. Connolly
Spencer M. Cuddy
Lowiek M. Hubers
Alexander C. Stehouwer
Stuart J. Connolly
Publication date
01-05-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-0969-x

Other articles of this Issue 4/2014

Journal of Thrombosis and Thrombolysis 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.